Shield Therapeutics PLC Stock
€0.049
Your prediction
Financial data and news for Shield
sharewise wants to provide you with the best news and tools for Shield, so we directly link to the best financial data sources.
Financials
News

Guardant Health (GH) Q2 Revenue Up 31%
Guardant Health (NASDAQ:GH), a precision oncology company specializing in advanced cancer diagnostics and screening, reported results for the second quarter of fiscal 2025 on July 30, 2025. The

Why Guardant Health Stock Surged Nearly 9% Higher Today
Precision oncology specialist Guardant Health (NASDAQ: GH) was something of a stock market star on Tuesday. On the back of very positive news in the regulatory sphere, the company's shares jumped